Low‐cost Fluorescein as an Alternative to Radio‐colloid for Sentinel Lymph Node Biopsy—a Prospective Validation Study in Early Breast Cancer
- 5 June 2020
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 44 (10) , 3417-3422
Abstract
Background: Sentinel lymph node biopsy (SLNB) using radio‐pharmaceutical (RP) and a blue dye is gold standard for axillary staging in clinically node‐negative early breast cancer. High costs and limited availability of RP and/or gamma probe are major deterrents in performing SLNB in developing countries. Fluorescence‐guided SLNB can obviate the need for RP and gamma probe. Fluorescein is an inexpensive fluorescent lymphatic tracer. In this study, we compared SLN identification rate (SLN‐IR) and false negative rates (FNR) of fluorescein‐guided SLNB and radio‐guided SLNB using 99mTc‐Sulfur‐colloid, in isolation, or in combination with methylene blue dye (MBD).Methods: Sixty‐five cN0 early and large operable breast cancer patients underwent validation SLNB using fluorescein (and blue LED light), 99mTc‐Sulfur‐colloid (and gamma probe) and MBD. Inj Fluorescein 4% was injected, 1 ml each peri‐tumoral and sub‐areolar five minutes before axillary incision. Axillary dissection was performed irrespective of SLNB histology. The SLN‐IR and FNR with various tracers and their combinations were compared.Results: The mean number of SLNs identified was 3.5 ± 1.8 (range 1–6). The SLN‐IR using RP alone was 94%, fluorescein alone was 92%, and MBD alone was 82%. The SLN‐IR using fluorescein plus MBD combination was 95.4%, compared to 97% using MBD plus RP combination. FNR was 6.3% using fluorescein plus MBD, as well as RP plus MBD combinations.Conclusions: SLN‐IR of > 90% and SLN‐FNR of < 10% using fluorescein plus MBD combination are in acceptable range, and are comparable to that of RP plus MBD combination. Fluorescein can replace RP for performing SLNB, in combination with MBD.Keywords
Funding Information
- Indian Council of Medical Research
This publication has 18 references indexed in Scilit:
- Fluorescence-Guided SurgeryFrontiers in Oncology, 2017
- Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort studyWorld Journal of Surgical Oncology, 2017
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update SummaryJournal of Oncology Practice, 2017
- The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic reviewBMC Cancer, 2016
- Abstract P2-01-31: Sentinel node mapping with fluorescein and comparison with methylene blue and technitium sulphur colloid in early breast cancerCancer Research, 2015
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal TumorsArchives of Surgery, 2004
- Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node LocalizationAnnals of Surgical Oncology, 2003
- Comparison of Intradermal and Subcutaneous Injections in Lymphatic MappingJournal of Surgical Research, 2001
- Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patientsJournal of Surgical Oncology, 2001